# Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study

> **NCT00689338** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 216 (actual)

## Conditions studied

- Invasive Candidiasis

## Interventions

- **DRUG:** Anidulafungin
- **DRUG:** Fluconazole
- **DRUG:** Voriconazole

## Key facts

- **NCT ID:** NCT00689338
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 216 (ACTUAL)
- **Last updated:** 2011-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00689338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00689338, "Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00689338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*